Printer Friendly

Articles from M2 Pharma (January 7, 2016)

1-12 out of 12 article(s)
Title Author Type Words
Actelion introduces UPTRAVI in US. 148
Akebia prices public offering of 7.25m common stock. 214
ANI Pharmaceuticals completes acquisition of Merck NDAs. 101
Cempra prices public offering of common stock at USD24.00 per share. 235
Epizyme prices public offering of common stock at USD9.00 per share. 228
Idera Pharmaceuticals names new director. 149
Pain Management Devices Market to Reach USD 6.3bn by 2023, According to Transparency Market Research. 498
Rani Therapeutics Teams with MedImmune to Evaluate Drug Delivery Platform. 301
Seres Therapeutics names new chief commercial officer and executive vice president. 153
SillaJen starts multinational randomised Phase three open-label study of Pexa-Vec. 163
US FDA Clears MiMedx to Export Allografts. 182
US FDA Clears MST's Image-Guided Software for Robotic Surgery. 212

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters